Research Article
15 August 2011

The Viral Nucleoprotein Determines Mx Sensitivity of Influenza A Viruses

ABSTRACT

Host restriction factors play a crucial role in preventing trans-species transmission of viral pathogens. In mammals, the interferon-induced Mx GTPases are powerful antiviral proteins restricting orthomyxoviruses. Hence, the human MxA GTPase may function as an efficient barrier against zoonotic introduction of influenza A viruses into the human population. Successful viruses are likely to acquire adaptive mutations allowing them to evade MxA restriction. We compared the 2009 pandemic influenza A virus [strain A/Hamburg/4/09 (pH1N1)] with a highly pathogenic avian H5N1 isolate [strain A/Thailand/1(KAN-1)/04] for their relative sensitivities to human MxA and murine Mx1. The H5N1 virus was highly sensitive to both Mx GTPases, whereas the pandemic H1N1 virus was almost insensitive. Substitutions of the viral polymerase subunits or the nucleoprotein (NP) in a polymerase reconstitution assay demonstrated that NP was the main determinant of Mx sensitivity. The NP of H5N1 conferred Mx sensitivity to the pandemic H1N1 polymerase, whereas the NP of pandemic H1N1 rendered the H5N1 polymerase insensitive. Reassortant viruses which expressed the NP of H5N1 in a pH1N1 genetic background and vice versa were generated. Congenic Mx1-positive mice survived intranasal infection with these reassortants if the challenge virus contained the avian NP. In contrast, they succumbed to infection if the NP of pH1N1 origin was present. These findings clearly indicate that the origin of NP determines Mx sensitivity and that human influenza viruses acquired adaptive mutations to evade MxA restriction. This also explains our previous observations that human and avian influenza A viruses differ in their sensitivities to Mx.

INTRODUCTION

Zoonotic transmissions pose a constant risk for the introduction of novel influenza A viruses into the human population (25). At the beginning of a pandemic, humans are normally immunologically naïve to the newly introduced viruses. Therefore, innate host defenses play a major role in preventing virus infection and spread (30). Influenza viruses trigger the synthesis of type I and type III interferons (IFNs), which in turn activate the expression of numerous IFN-inducible genes, including the Mx genes (1, 29, 30). Mx proteins belong to the family of dynamin-like large GTPases and are found in many species (10). The human MxA protein and the murine Mx1 protein have antiviral properties and also protect cells from infection with influenza A viruses (10, 11). The protective role of Mx proteins is best illustrated in mice carrying the wild-type Mx1 resistance gene (8, 9). Mx1-positive (Mx1+/+) mice are highly resistant to influenza virus infection and survive large challenge doses, whereas Mx1-negative (Mx1−/−) mice with defective Mx1 alleles are susceptible and die (24, 31).
Mx proteins are known to block an early step in the influenza virus replication cycle. After entering a cell, the viral nucleocapsids (also called vRNPs) are imported into the cell nucleus, where the associated viral RNA polymerase becomes active and starts primary transcription. This process is inhibited by the murine Mx1 protein, which is located in the nucleus (18). Human MxA is predominantly cytoplasmic and interferes with secondary transcription and viral replication (22). A variant of MxA carrying a foreign nuclear localization signal moves into the nucleus and blocks primary transcription, exactly as does murine Mx1 (5, 35). This nuclear MxA variant was shown to form a complex with the influenza virus nucleoprotein (NP), and NP could also be coimmunoprecipitated with wild-type MxA under cross-linking conditions (32). Influenza virus strains were recently found to differ in their sensitivities to the antiviral effect of Mx proteins. Avian influenza viruses proved to be more sensitive than human strains, and this was influenced by the viral NP in vRNP reconstitution assays (4).
Here we compared the Mx sensitivity of the 2009 pandemic influenza virus A/Hamburg/4/09 (pH1N1) strain with that of the highly pathogenic avian influenza virus A/Thailand/1(KAN-1)/04 (H5N1) strain. Moreover, we determined the role of the NP in Mx sensitivity, using reconstituted polymerase assays as well as reassortant viruses for infection of Mx-positive cells and mice. Our results demonstrate that the viral NP determines Mx sensitivity and that the NP of the pandemic 2009 virus is relatively Mx insensitive. They also suggest that human MxA may provide a natural barrier to transmission of influenza A viruses from avian reservoirs and that a degree of Mx resistance may develop due to natural selection in the human population.
(This work was conducted by Petra Zimmermann in partial fulfillment of the requirements for a Ph.D. degree from the Faculty of Biology of the University of Freiburg, Freiburg, Germany.)

MATERIALS AND METHODS

Cells and viruses.

Mouse 3T3 cell lines expressing murine Mx1 (3T3-Mx1), human MxA (3T3-MxA), or Mx-negative control cells (3T3) have been described previously (22). 3T3 cells, MDCK cells, and HEK 293T cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum, 2 mM l-glutamine, and penicillin-streptomycin.

Generation of recombinant influenza A viruses.

Recombinant viruses, including pH1N1 (A/Hamburg/4/09), H5N1 [A/Thailand/1(KAN-1)/04], and the NP-reassortant viruses H5N1-NP(pH1N1) and pH1N1-NP(H5N1), were generated under biosafety level (BSL) 3 conditions by the eight-plasmid reverse-genetics system as described previously (12, 20, 26). For generation of the pH1N1 viruses, the HA rescue plasmid was mutated by quick-change site-directed mutagenesis to encode the mouse-adapted mutations D131E and S186P (34). Successful introduction of these mutations was confirmed by sequencing. All recombinant viruses were plaque purified on MDCK cells in the presence of 1 μg/ml of tosylsulfonyl-phenylalanyl-chloromethyl keton (TPCK)-treated trypsin. Virus stocks were prepared on MDCK cells, and titers were determined by plaque assay.

Mice.

BALB/c mice with defective Mx1 alleles and congenic BALB.A2G-Mx1 mice (designated BALB-Mx1) carrying the functional Mx1 allele (28) were bred locally. Six- to eight-week-old mice were anesthetized with a mixture of ketamine (100 μg per gram body weight) and xylazine (5 μg per gram) administered intraperitoneally (i.p.) and inoculated intranasally (i.n.) with the indicated doses of viruses in 50 μl phosphate-buffered saline (PBS) containing 0.3% bovine serum albumin (BSA). Mice were monitored daily for weight loss until 12 days postinfection (p.i.). Animals with severe symptoms or more than 25% weight loss were euthanized. For determination of lung titers and histopathological analysis, mice were euthanized at the indicated time points. All animal work was conducted under BSL 3 conditions in accordance with the guidelines of the local animal care committee.

Titration of virus in lungs.

Mice were infected i.n. with 1,000 PFU of the indicated viruses. Lungs from infected mice were collected at 48 h p.i. and homogenized using the FastPrep24 system (MP Biomedicals). Tissue debris was removed by low-speed centrifugation, and virus titers in supernatants were determined by performing 10-fold serial dilutions in PBS with 0.3% BSA followed by plaque assay on MDCK cells.

Virus growth curves.

MDCK cells seeded in 6-well plates were incubated with virus at a multiplicity of infection (MOI) of 0.001 in PBS containing 0.3% BSA for 1 h at 37°C. The inoculum was removed, and 2 ml infection medium (DMEM supplemented with 0.3% BSA), additionally containing 1 μg/ml TPCK-treated trypsin for pH1N1 viruses, was added. Virus titers in cell culture supernatants were determined at the indicated time points by plaque assay and are expressed as PFU per ml.

Tissue culture infection experiments.

Mouse 3T3 cells were seeded at 106 cells per well in 6-well plates and infected at an MOI of 5 for 1 h at 37°C. Subsequently, the inoculum was replaced by infection medium. Cells were lysed in buffer containing 50 mM HEPES (pH 7.3), 125 mM NaCl, 1 mM EDTA, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 1 mM dithiothreitol (DTT), 25 U/ml of Benzonase, and protease inhibitors (Roche). Proteins were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and analyzed by Western blotting. The blots were probed with the monoclonal antibody M143 to detect Mx proteins (6), monoclonal mouse anti-PA antibody (G. Chase et al., unpublished data), and a rabbit antiactin antibody (Sigma). Horseradish peroxidase-labeled secondary antibodies and a chemiluminescence detection system (Pierce femto kit) were used to detect primary antibodies. Signal quantification was performed using ChemiDoc XRS equipment (Bio-Rad).

Influenza A virus polymerase reconstitution assay (minireplicon assay).

HEK 293T cells seeded in 12-well plates were transfected using the Nanofectin transfection reagent (PAA Laboratories) according to the manufacturer's protocol. Ten nanograms of pCAGGs plasmids encoding PB2, PB1, and PA and 100 ng of NP-encoding plasmid were cotransfected with 50 ng of the firefly luciferase-encoding viral minigenome construct pPolI-FFLuc-RT, which is flanked by the noncoding regions of segment 8 of influenza A virus (4). The transfection mixture also contained 25 ng of pRL-SV40, a plasmid constitutively expressing Renilla luciferase under the control of the simian virus 40 promoter, used to normalize variations in transfection efficiency. To evaluate the antiviral potential of Mx1, we cotransfected increasing amounts of Mx1-encoding plasmid. Cotransfection of the antivirally inactive mutant Mx1 (K49A) (23) was used as a control. To achieve equal amounts of transfected DNA, an empty vector plasmid was added. Twenty-four hours posttransfection, cells were lysed and firefly and Renilla luciferase activities were determined using the dual luciferase reporter assay (Promega) according to the manufacturer's protocol. Relative polymerase activity was calculated as the ratio of luciferase to Renilla luminescence.

Histopathological analysis.

Lungs were collected from BALB-Mx1 mice 3 and 4 days p.i. Lungs were inflated and fixed in 4% formaldehyde overnight at 4°C and subsequently embedded in paraffin. Sections (4 μm) were stained with hematoxylin and eosin (H&E) and examined under the light microscope for histopathological changes. Representative images were obtained on a Nicon Eclipse E400 microscope at magnification ×10.

RESULTS

Mx sensitivity differs between human and avian influenza A virus strains.

Since Mx1 interferes with the transcriptional activity of vRNPs (4), we determined the polymerase activities of influenza virus strains A/Hamburg/4/09 (pH1N1) and A/Thailand/1(KAN-1)/04 (H5N1) in a minireplicon system in the presence or absence of Mx1. The H5N1 polymerase activity decreased to almost 10% at the largest amount (200 ng) of cotransfected Mx1-expressing plasmid, whereas the pH1N1 polymerase activity was reduced to only 60% (Fig. 1A). The dose of Mx1-expressing plasmid necessary to achieve 50% inhibition of the H5N1 polymerase activity (ID50) was found to be 25 ng (Fig. 1A). These results demonstrate that the polymerase of the pandemic H1N1 isolate is less sensitive to Mx1 inhibition than the polymerase of the avian H5N1 strain.
Fig. 1.
Fig. 1. The origin of NP determines Mx1 sensitivity of influenza A virus polymerase activity. The viral polymerase of A/Hamburg/4/09, designated pH1N1, and that of A/Thailand/1(KAN-1)/04, designated H5N1, were reconstituted in 293T cells by transfection with 50 ng of a firefly luciferase (FF-luc)-encoding viral minigenome construct, 10 ng of expression constructs encoding the viral polymerase subunits PB2, PB1, and PA of the respective strain, and 100 ng of the indicated NP-encoding plasmids. In addition, the indicated amounts of Mx1-encoding plasmids were cotransfected. Twenty-four hours posttransfection, cells were lysed and luciferase activities were measured. Cotransfection of the inactive mutant Mx1 (K49A) was used as a control, and polymerase activity in the presence of Mx1 (K49A) was set to 100%. Mean values of data from three independent experiments are shown. Mx1 expression was monitored by Western blot analysis. Actin was used as a loading control (lower panels in A, C, and D). Dotted lines indicate the amount of Mx1-encoding plasmid necessary for 50% inhibition of polymerase activity. (A) H5N1 and pH1N1 polymerase activity in the presence of increasing concentrations of Mx1. (B) Polymerase activity after exchange of single vRNP components in the presence of 100 ng of Mx1-encoding plasmid. (C) pH1N1 polymerase activity in the presence of increasing concentrations of Mx1 and either NP of pH1N1 [NP (pH1N1)] or H5N1 [NP (H5N1)]. (D) H5N1 polymerase activity in the presence of increasing concentrations of Mx1 and NP of either H5N1 [NP (H5N1)] or pH1N1 [NP (pH1N1)].

Mx sensitivity correlates with the nature of the NP.

To identify the viral factor determining Mx sensitivity, we exchanged each protein component of the resistant pH1N1 vRNP (i.e., the NP and the three polymerase subunits PA, PB1, and PB2) with the corresponding components of the sensitive H5N1 strain and determined the activity of the reassorted vRNPs in the minireplicon assay. The NP of H5N1 origin increased the Mx1 sensitivity of the pH1N1 polymerase (Fig. 1B and C), resulting in a drop in the ID50 from over 200 ng to 36 ng of transfected Mx1 expression plasmids. In contrast, substitutions with the polymerase subunit PA, PB1, or PB2 of H5N1 did not result in enhanced Mx1 sensitivity (Fig. 1B). Conversely, the pH1N1 NP rendered the H5N1 polymerase activity relatively resistant to Mx1 inhibition (Fig. 1B and D), as demonstrated by an increase in the ID50 from 25 ng to 173 ng of transfected Mx1 expression plasmids. In the absence of Mx1, the activities of both the pH1N1 and H5N1 polymerases were not affected by the source of the NP (data not shown), excluding the possibility that subunit incompatibilities were affecting Mx1 sensitivity. Together, these data indicate that the nature of the NP is the main determinant of Mx sensitivity.

The NP of avian H5N1 origin increases Mx sensitivity of the reassortant pH1N1 virus.

To verify the importance of NP as a determinant of Mx1 sensitivity in vivo, we generated two recombinant strains, namely, wild-type strain A/Hamburg/4/09 (H1N1) (here designated pH1N1) and a reassortant A/Hamburg/4/09 strain which carries the NP gene of A/Thailand/1(KAN-1)/04 (H5N1) and is here designated pH1N1-NP(H5N1). Since pandemic H1N1 viruses are almost avirulent in BALB/c mice (14), we introduced two mutations (D131E and S186P) into the hemagglutinin (HA) protein, which have been described as increasing virulence (13, 34). Both pH1N1 and pH1N1-NP(H5N1) grew to comparable titers in MDCK cells infected with an MOI of 0.001. However, infection with the latter virus resulted in slightly higher titers 24 h p.i. (Fig. 2A). To test the replication efficiency of both viruses in Mx-expressing cells, we took advantage of stably transformed Swiss 3T3 cells that express high levels of murine Mx1 or human MxA under the control of a constitutive promoter (22) (Fig. 2B). The cells were infected with either pH1N1 or pH1N1-NP(H5N1) at an MOI of 5, and viral replication was monitored 10 or 12 h later by determining viral protein expression. The two viruses replicated with comparable efficiencies in Swiss 3T3 cells that do not express Mx proteins, as indicated by equal amounts of PA protein levels (Fig. 2C, lanes 1 to 4). The two types of viruses replicated less well in both Mx1- and MxA-expressing cells, as expected (Fig. 2C and D). However, their replication efficiencies differed significantly in the presence of either Mx1 or MxA. The PA antigen signals were much weaker following infection with the reassortant pH1N1-NP(H5N1) virus than with parental pH1N1 (Fig. 2C, lane 5 to 12). Quantification of PA signal intensities from three independent experiments confirmed the differential reduction in antigen expression levels in infected cells (Fig. 2D). These results indicate that the NP is responsible for the relative resistance of pH1N1 viruses toward the antiviral action of mouse and human Mx GTPases.
Fig. 2.
Fig. 2. The NP of avian H5N1 origin increases Mx sensitivity of a reassortant pH1N1 virus. (A) Growth kinetics of pH1N1 and pH1N1-NP(H5N1) in MDCK cells after infection at an MOI of 0.001. Culture supernatants were collected at the indicated time points, and virus titers were determined by plaque assay. Error bars represent the standard errors of the means of data from three independent experiments. (B) Mx expression in Swiss 3T3 cells expressing either recombinant murine Mx1 (3T3-Mx1), human MxA (3T3-MxA), or no Mx proteins (3T3) was monitored by Western blot analysis. (C) The indicated Swiss 3T3 control and Mx-expressing cells were infected with 5 MOI of pH1N1 or pH1N1-NP(H5N1). At the indicated time points p.i., cells were lysed and viral PA protein expression was monitored by Western blot analysis. Cellular actin was detected as a loading control. (D) PA signals of the experiment shown in panel C and two additional independent experiments were quantified and normalized to actin. The P values were calculated by Student's t test comparing individual time points. ***, P < 0.001; ns, not significant.
To evaluate the in vivo growth capacities of pH1N1 and pH1N1-NP(H5N1), Mx1-negative BALB/c mice were infected i.n. with 1,000 PFU. For both viruses, comparable lung titers were obtained after 48 h which were in the range of 107 PFU/ml (Fig. 3A, left panel). These results indicated that the NP of H5N1 is well tolerated and does not compromise fitness of the reassortant pH1N1 virus. Next, Mx1-positive BALB-Mx1 mice were challenged with a high dose of either parental pH1N1 or reassortant pH1N1-NP(H5N1) virus. All animals infected with the parental virus showed dramatic body weight loss, and 70% of the animals succumbed within 4 days (Fig. 3B and C). In contrast, infection with the reassortant pH1N1-NP(H5N1) virus caused only moderate weight loss, and all animals survived (Fig. 3B and C). To exclude the possibility that the high virulence of pH1N1 resulted from a general suppression of the interferon response, Mx1 expression in animals was monitored 48 h after infection. Western blot analyses of lung homogenates demonstrated that both viruses induced the same amount of Mx1 protein (Fig. 3D). To determine whether the clinical signs correlated with enhanced virus replication, BALB-Mx1 mice were infected with 1,000 PFU of either pH1N1 or pH1N1-NP(H5N1), and lung titers were determined 48 h after infection. Viral titers were 10-fold higher in animals infected with pH1N1 than in animals infected with pH1N1-NP(H5N1) (Fig. 3A, right panel). To determine whether the difference in lethality between pH1N1 and pH1N1-NP(H5N1) correlated with altered lung pathology, histological tissue sections of Mx-positive mice were examined 4 days after infection (Fig. 3E). Lungs of mice infected with pH1N1 had a greater number of lesions and displayed more massive infiltration of inflammatory cells than lungs of mice infected with pH1N1-NP(H5N1). Together, these data indicate that the nature of NP determines viral replication efficiency and lung pathology in Mx1-positive mice.
Fig. 3.
Fig. 3. NP determines virulence of pH1N1 in Mx1-positive mice. (A) BALB/c (left columns) and BALB-Mx1 (right columns) mice were inoculated i.n. with 1,000 PFU of the indicated viruses. Lungs from infected mice (n = 5) were collected 48 h p.i. and homogenized, and virus titers were determined by plaque assay. (B and C) Changes in body weight (B) or survival (C) of BALB-Mx1 mice (n = 10/group) intranasally infected with 2 × 106 PFU of pH1N1 and pH1N1-NP(H5N1). Survival and weight loss were monitored daily for 12 days. The P values for changes in weight loss between the two groups were calculated by Student's t test comparing individual time points. ** and ***, P < 0.01 and 0.001, respectively. (D) Mx1 expression levels in lungs of mice infected with 2 × 106 PFU were determined 48 h p.i. by Western blot analysis of lung homogenates. (E) Histopathological analysis of lungs from BALB-Mx1 mice intranasally infected with 2 × 106 PFU of the indicated viruses 4 days p.i. Serial sections were examined for histopathological changes following hematoxylin-and-eosin (H&E) staining, and representative images were captured at magnification ×10. Sections are representative of three mice per group. uninf., uninfected.

The NP of the 2009 pandemic H1N1 virus confers increased Mx resistance to an avian virus.

The NP of the pandemic H1N1 isolate A/Hamburg/4/09 negatively affected the Mx sensitivity of the H5N1 polymerase of A/Thailand/1(KAN-1)/04, as assessed in a minireplicon system (Fig. 1C). We therefore anticipated that an A/Thailand/1(KAN-1)/04 reassortant virus equipped with the pH1N1 NP gene should gain increased Mx resistance. To prove this, we generated recombinant wild-type A/Thailand/1(KAN-1)/04, designated H5N1, and a reassortant of this parental virus, designated H5N1-NP(pH1N1), coding for the NP protein of A/Hamburg/4/09. Growth of the reassortant virus in MDCK cells infected at a low MOI of 0.001 was significantly impaired by up to 2 log10 compared to that of the parental H5N1 strain (Fig. 4A). However, after infection at a high MOI of 5, the two viruses replicated with comparable efficiencies in Swiss 3T3 cells that do not express Mx proteins, as demonstrated by the accumulation of equal amounts of PA protein (Fig. 4B, lanes 1 to 4). Importantly, the replication efficiency of H5N1 and H5N1-NP(pH1N1) clearly differed in Mx-expressing cells. Compared to cells infected with H5N1-NP(pH1N1), expression of the viral PA protein was strongly reduced in H5N1-infected cells, irrespective of whether they expressed murine Mx1 or human MxA (Fig. 4B, lanes 5 to 12). Quantification of PA signal intensities from three independent experiments confirmed that the observed differences between H5N1-NP(pH1N1) and H5N1 were significant (Fig. 4C). These findings indicated that the NP of the human pH1N1 strain is able to confer partial Mx resistance to the otherwise sensitive avian H5N1 virus.
Fig. 4.
Fig. 4. The NP of the 2009 pandemic H1N1 virus confers increased Mx resistance to an avian virus. (A) MDCK cells were infected at an MOI of 0.001 with the indicated viruses. Virus titers in the culture supernatants were determined by plaque assay at the indicated time points. Error bars represent the standard errors of the means of data from three independent experiments. (B) Swiss 3T3 control and Mx1- or MxA-expressing cells were infected with 5 MOI of the indicated viruses. At 5 and 6 h p.i., cells were lysed, and viral PA protein expression was monitored by Western blot analysis. Actin was used as a loading control. (C) Signals of PA obtained for panel B and in two additional independent experiments were quantified and normalized to actin expression. The P values were calculated by Student's t test, comparing individual time points. *, **, and ***, P < 0.05, 0.01, and 0.001, respectively. ns, not significant. (D) Viral lung titers from BALB/c and BALB-Mx1 mice infected i.n. with 1,000 PFU of the indicated viruses. Lungs from infected mice (n = 5) were collected 48 h p.i. and homogenized, and virus titers were determined by plaque assay. (E) Mx1 expression levels in lungs of BALB-Mx1 mice (n = 2) infected with 106 PFU were determined 48 h p.i. by Western blot analysis of lung homogenates. (F and G) BALB-Mx1 mice (n = 14/group) were infected i.n. with 106 PFU of the indicated viruses and monitored daily for weight loss (F) and survival (G). (H) Histopathological analysis of lungs from BALB-Mx1 mice infected i.n. with 106 PFU of the indicated viruses 3 days p.i. Serial sections were examined for histopathological changes following hematoxylin-and-eosin (H&E) staining. Images were captured at magnification ×10 and are representative of three mice per group.
Next, we determined the growth capacity of H5N1 and H5N1-NP(pH1N1) in lungs of Mx1-negative BALB/c mice. Viral lung titers of animals infected with 1,000 PFU of reassortant H5N1-NP(pH1N1) were 100-fold lower than the titers observed for mice infected with parental H5N1 virus, in full agreement with the decreased viral replication found in cell culture (Fig. 4D, left panel). Similar differences in viral lung titers between the two virus strains were also observed in BALB-Mx1 mice (Fig. 4D, right panel), indicating that the reassortant H5N1-NP(pH1N1) virus is attenuated in both Mx1-positive and Mx1-negative mice. However, despite these differences in viral growth, the induction of Mx1 in the lungs at 48 h after infection with 106 PFU was comparable (Fig. 4E). Notably, intranasal infection of BALB-Mx1 mice with 106 PFU of H5N1-NP(pH1N1) virus caused rapid weight loss (Fig. 4F) and almost 100% mortality (Fig. 4G). In contrast, all H5N1-infected animals recovered rapidly (Fig. 4F) and survived (Fig. 4G). Consistent with the clinical outcome, multiple foci of extended inflammatory cell infiltrates and thickening of bronchiolar and alveolar walls were observed 3 days after infection with H5N1-NP(pH1N1) virus (Fig. 4H). On the contrary, the pulmonary pathology in mice infected with H5N1 was only moderate (Fig. 4H). Thus, despite causing considerable attenuation in mice, NP of pH1N1 rendered the H5N1 virus less sensitive to Mx1 restriction, thereby resulting in increased lung pathology and death of infected animals.

DISCUSSION

Here we have shown that the pandemic H1N1 virus A/ Hamburg/4/09 is less sensitive to the inhibitory actions of the human MxA and mouse Mx1 proteins than the highly pathogenic avian H5N1 virus A/Thailand/01/04. Introduction of the avian H5N1 NP into the pandemic H1N1 virus abrogated its partial Mx resistance. We also show that the NP of pandemic H1N1 virus was able to render the avian H5N1 virus less sensitive to Mx restriction both in cell culture and in mice. These results indicate that NP is a major viral determinant of Mx sensitivity.
Infection of Mx1-positive mice with the pandemic H1N1 virus resulted in increased titers in lungs compared to infection with the reassortant pH1N1-NP(H5N1) virus and caused more-severe histopathological changes in the lung. Similar severe lung pathology was observed after infection with the reassortant H5N1-NP(pH1N1) virus. The lung viral titers, however, were significantly lower than the lung viral titers of mice infected with the parental H5N1 virus. Thus, increased replication efficiencies in the lung do not necessarily correlate with lung pathology and disease outcome. This discrepancy between reduced replication efficiency and enhanced morbidity and mortality in influenza A virus-infected mice has already been noticed by others (2, 19). We can only speculate that other factors, such as enhanced replication in specific cell types, dysregulation of pulmonary cytokines, or other deleterious effects on tissue integrity might have contributed to the severe pathogenicity of pH1N1 and H5N1-NP(pH1N1).
The present data with the reassortant viruses clearly suggest that the viral NP is the target of Mx action. A direct physical interaction between MxA and influenza A virus NP was previously demonstrated in immunoprecipitation assays under cross-linking conditions (32). Furthermore, there is compelling biochemical evidence for recognition and binding of the nucleocapsids of Thogoto virus by human MxA (16, 17, 33). Thogoto virus is an influenza virus-like virus transmitted by ticks. It is highly sensitive to the antiviral action of MxA (17) and may display high-affinity binding sites for the MxA GTPase. We have previously shown that MxA has to form highly ordered oligomers to exert its antiviral function (7). The structural details of MxA oligomerization have recently been elucidated (7). They suggest that oligomerization is a stepwise process. The model predicts that MxA tetramers oligomerize on the well-ordered surface of viral nucleocapsids into filamentous or ring-like structures, thereby inhibiting the transcriptional activity of the viral polymerase complex (10). Processivity may largely depend on appropriate binding sites on the viral NP. Even small changes in the amino acid composition of NP may greatly affect the strength of MxA binding, oligomerization, and antiviral activity.
Introduction of the NP of pH1N1 origin into the H5N1 virus caused considerable attenuation of the reassortant virus in cell culture and in mice. This was interesting, because the polymerase activity of the reassortant strain remained unchanged in a minireplicon system. The present findings are in agreement with those of a recent study for which a high degree of compatibility between components of the viral polymerase complex of avian H5N1 and pandemic H1N1 strains, resulting in normal polymerase activity but strong attenuation of viral growth, was reported (21). Importantly, the reassortant H5N1-NP(pH1N1) virus used in the present study showed increased Mx resistance in tissue culture and in vivo, in addition to its partial attenuation. It is conceivable that a gain of Mx resistance may reduce virus fitness. If this were the case, successful adaptation of avian viruses would require additional mutations to compensate for the growth defects caused by Mx escape mutations in the NP. Surprisingly, introduction of avian NP into the pandemic H1N1 strain was well tolerated and did not affect viral fitness in the absence of Mx, indicating that the polymerase complex of this pandemic H1N1 strain has gained a remarkable flexibility in the cooperation with NPs of distantly related strains. This capacity may have enabled the pandemic H1N1 progenitor virus to gain Mx resistance without obvious attenuation, facilitating its successful transmission and spread in 2009.
A picture is beginning to emerge which has implications for influenza virus evolution and epidemiology. Virtually all NPs of human influenza virus strains studied so far (including the pandemic H1N1 isolate from 2009 described in this study or the pandemic virus of 1918) show increased resistance to the antiviral action of mammalian Mx proteins, whereas the NPs of avian origin [including the H5N1 strain A/Thailand/(KAN-1)/04 and others] are highly Mx sensitive (4; this study). Mx genes are also present in avian species, and some antiviral activity for chicken Mx linked to a serine-to-asparagine polymorphism at position 631 has been described (15). However, recent studies could not detect any antiviral effect of chicken Mx proteins against different strains of influenza A viruses (3, 27). In any case, it is conceivable that newly emerging influenza A viruses acquire adaptive mutations in the mammalian host which allow them to escape Mx restriction. As yet, the amino acids that determine Mx resistance are not known. We are currently investigating the 32 amino acids of NP which differ between the pandemic H1N1 and the avian H5N1 strain to identify the crucial amino acid patch required for Mx sensitivity.

ACKNOWLEDGMENTS

We thank Daniel Mayer for helpful discussions and suggestions, Geoffrey Chase and Linda Brunotte for critical reading, and H.-D. Klenk for providing the A/Hamburg/4/09 rescue plasmids.
Parts of this work were supported by grants from the Deutsche Forschungsgemeinschaft (Ko1579/8-1) to G.K., from the Mueller-Fahnenberg-Stiftung at the Medical Faculty of the University of Freiburg to G.K., and from the Bundesministerium für Bildung und Forschung (BMBF) (FluResearchNet) to M.S. and by EU grant FLUINNATE 044161 to O.H.

REFERENCES

1.
Ank N. and Paludan S. R. 2009. Type III IFNs: new layers of complexity in innate antiviral immunity. Biofactors 35:82–87.
2.
Belser J. A. et al. 2010. Pathogenesis of pandemic influenza A (H1N1) and triple-reassortant swine influenza A (H1) viruses in mice. J. Virol. 84:4194–4203.
3.
Benfield C. T., Lyall J. W., Kochs G., and Tiley L. S. 2008. Asparagine 631 variants of the chicken Mx protein do not inhibit influenza virus replication in primary chicken embryo fibroblasts or in vitro surrogate assays. J. Virol. 82:7533–7539.
4.
Dittmann J. et al. 2008. Influenza A virus strains differ in sensitivity to the antiviral action of Mx-GTPase. J. Virol. 82:3624–3631.
5.
Engelhardt O. G., Sirma H., Pandolfi P. P., and Haller O. 2004. Mx1 GTPase accumulates in distinct nuclear domains and inhibits influenza A virus in cells that lack promyelocytic leukaemia protein nuclear bodies. J. Gen. Virol. 85:2315–2326.
6.
Flohr F., Schneider-Schaulies S., Haller O., and Kochs G. 1999. The central interactive region of human MxA GTPase is involved in GTPase activation and interaction with viral target structures. FEBS Lett. 463:24–28.
7.
Gao S. et al. 2010. Structural basis of oligomerization in the stalk region of dynamin-like MxA. Nature 465:502–506.
8.
Haller O. 1981. Inborn resistance of ice to orthomyxoviruses. Curr. Top. Microbiol. Immunol. 92:25–52.
9.
Haller O., Arnheiter H., Gresser I., and Lindenmann J. 1979. Genetically determined, interferon-dependent resistance to influenza virus in mice. J. Exp. Med. 149:601–612.
10.
Haller O., Gao S., von der Malsburg A., Daumke O., and Kochs G. 2010. Dynamin-like MxA GTPase: structural insights into oligomerization and implications for antiviral activity. J. Biol. Chem. 285:28419–28424.
11.
Haller O. and Kochs G. 2011. Human MxA protein: an interferon-induced dynamin-like GTPase with broad antiviral activity. J. Interferon Cytokine Res. 31:79–87.
12.
Hoffmann E., Neumann G., Kawaoka Y., Hobom G., and Webster R. G. 2000. A DNA transfection system for generation of influenza A virus from eight plasmids. Proc. Natl. Acad. Sci. U. S. A. 97:6108–6113.
13.
Ilyushina N. A. et al. 2010. Adaptation of pandemic H1N1 influenza viruses in mice. J. Virol. 84:8607–8616.
14.
Itoh Y. et al. 2009. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 460:1021–1025.
15.
Ko J. H. et al. 2002. Polymorphisms and the differential antiviral activity of the chicken Mx gene. Genome Res. 12:595–601.
16.
Kochs G. and Haller O. 1999. GTP-bound human MxA protein interacts with the nucleocapsids of Thogoto virus (Orthomyxoviridae). J. Biol. Chem. 274:4370–4376.
17.
Kochs G. and Haller O. 1999. Interferon-induced human MxA GTPase blocks nuclear import of Thogoto virus nucleocapsids. Proc. Natl. Acad. Sci. U. S. A. 96:2082–2086.
18.
Krug R. M., Shaw M., Broni B., Shapiro G., and Haller O. 1985. Inhibition of influenza viral mRNA synthesis in cells expressing the interferon-induced Mx gene product. J. Virol. 56:201–206.
19.
Lu X. et al. 2001. Immunity to influenza A H9N2 viruses induced by infection and vaccination. J. Virol. 75:4896–4901.
20.
Manz B., Matrosovich M., Bovin N., and Schwemmle M. 2010. A polymorphism in the hemagglutinin of the human isolate of a highly pathogenic H5N1 influenza virus determines organ tropism in mice. J. Virol. 84:8316–8321.
21.
Octaviani C. P., Ozawa M., Yamada S., Goto H., and Kawaoka Y. 2010. High level of genetic compatibility between swine-origin H1N1 and highly pathogenic avian H5N1 influenza viruses. J. Virol. 84:10918–10922.
22.
Pavlovic J., Haller O., and Staeheli P. 1992. Human and mouse Mx proteins inhibit different steps of the influenza virus multiplication cycle. J. Virol. 66:2564–2569.
23.
Pitossi F. et al. 1993. A functional GTP-binding motif is necessary for antiviral activity of Mx proteins. J. Virol. 67:6726–6732.
24.
Salomon R. et al. 2007. Mx1 gene protects mice against the highly lethal human H5N1 influenza virus. Cell Cycle 6:2417–2421.
25.
Salomon R. and Webster R. G. 2009. The influenza virus enigma. Cell 136:402–410.
26.
Seibert C. W. et al. 2010. Oseltamivir-resistant variants of the 2009 pandemic H1N1 influenza A virus are not attenuated in the guinea pig and ferret transmission models. J. Virol. 84:11219–11226.
27.
Sironi L. et al. 2008. Susceptibility of different chicken lines to H7N1 highly pathogenic avian influenza virus and the role of Mx gene polymorphism coding amino acid position 631. Virology 380:152–156.
28.
Staeheli P., Horisberger M. A., and Haller O. 1984. Mx-dependent resistance to influenza viruses is induced by mouse interferons alpha and beta but not gamma. Virology 132:456–461.
29.
Stetson D. B. and Medzhitov R. 2006. Type I interferons in host defense. Immunity 25:373–381.
30.
Takeuchi O. and Akira S. 2009. Innate immunity to virus infection. Immunol. Rev. 227:75–86.
31.
Tumpey T. M. et al. 2007. The Mx1 gene protects mice against the pandemic 1918 and highly lethal human H5N1 influenza viruses. J. Virol. 81:10818–10821.
32.
Turan K. et al. 2004. Nuclear MxA proteins form a complex with influenza virus NP and inhibit the transcription of the engineered influenza virus genome. Nucleic Acids Res. 32:643–652.
33.
Weber F., Haller O., and Kochs G. 2000. MxA GTPase blocks reporter gene expression of reconstituted Thogoto virus ribonucleoprotein complexes. J. Virol. 74:560–563.
34.
Ye J. et al. 2010. Variations in the hemagglutinin of the 2009 H1N1 pandemic virus: potential for strains with altered virulence phenotype? PLoS Pathog. 6:e1001145.
35.
Zürcher T., Pavlovic J., and Staeheli P. 1992. Mechanism of human MxA protein action: variants with changed antiviral properties. EMBO J. 11:1657–1661.

Information & Contributors

Information

Published In

cover image Journal of Virology
Journal of Virology
Volume 85Number 1615 August 2011
Pages: 8133 - 8140
PubMed: 21680506

History

Received: 8 April 2011
Accepted: 1 June 2011
Published online: 15 August 2011

Permissions

Request permissions for this article.

Contributors

Authors

Petra Zimmermann
Department of Virology, Institute for Medical Microbiology and Hygiene, University of Freiburg, Hermann-Herder-Strasse 11, 79104 Freiburg, Germany
Benjamin Mänz
Department of Virology, Institute for Medical Microbiology and Hygiene, University of Freiburg, Hermann-Herder-Strasse 11, 79104 Freiburg, Germany
Otto Haller
Department of Virology, Institute for Medical Microbiology and Hygiene, University of Freiburg, Hermann-Herder-Strasse 11, 79104 Freiburg, Germany
Martin Schwemmle [email protected]
Department of Virology, Institute for Medical Microbiology and Hygiene, University of Freiburg, Hermann-Herder-Strasse 11, 79104 Freiburg, Germany
Georg Kochs [email protected]
Department of Virology, Institute for Medical Microbiology and Hygiene, University of Freiburg, Hermann-Herder-Strasse 11, 79104 Freiburg, Germany

Metrics & Citations

Metrics

Note:

  • For recently published articles, the TOTAL download count will appear as zero until a new month starts.
  • There is a 3- to 4-day delay in article usage, so article usage will not appear immediately after publication.
  • Citation counts come from the Crossref Cited by service.

Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. For an editable text file, please select Medlars format which will download as a .txt file. Simply select your manager software from the list below and click Download.

View Options

Figures

Tables

Media

Share

Share

Share the article link

Share with email

Email a colleague

Share on social media

American Society for Microbiology ("ASM") is committed to maintaining your confidence and trust with respect to the information we collect from you on websites owned and operated by ASM ("ASM Web Sites") and other sources. This Privacy Policy sets forth the information we collect about you, how we use this information and the choices you have about how we use such information.
FIND OUT MORE about the privacy policy